Evaluation of the Effect of a Low-FODMAP Diet on Gastrointestinal Symptoms and Inflammatory Markers in Fabry Patients | MicrobiomeTrials← Back to trialsNCT07888998
Evaluation of the Effect of a Low-FODMAP Diet on Gastrointestinal Symptoms and Inflammatory Markers in Fabry Patients
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-01-02Est. Completion: 2027-01-30
Enrollment target: 30 participants Locations- Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Fatih, Turkey (Türkiye)
Other microbiome trials you might be interested in
Fabry Disease
An open-label study to evaluate the safety, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of migalastat tre…
Atlanta, United StatesEst. completion Dec 2027
SplenomegalySplenectomyThrombopeniaInterstitial Lung Disease (ILD)Hypocholesterolemia
The goal of this clinical trial is to optimise and facilitate screening for Acid SphingoMyelinase Deficiency (ASMD) dise…
Paris, FranceEst. completion Mar 1, 2029